Home Blood Pressure Variability and Its Link to Arteriosclerosis and Metabolic Dysfunction in Hypertensive Patients
Recruiting · NCT06394934 · Observational (researchers observe without assigning treatment) · Lead sponsor: Korea University Anam Hospital
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
This observational study investigates the correlation between home blood pressure variability (BPV) and arteriosclerosis, alongside metabolic indicators, in hypertensive patients over a three-year period. The research specifically focuses on the predictive value of home BPV for major adverse cardiovascular events (MACE) including myocardial infarction, stroke, and heart failure hospitalizations. Utilizing a mobile application called Healthscan for daily BP monitoring, the study aims to enhance the understanding of how BPV impacts cardiovascular and metabolic health in a real-world setting.
Who can take part
Inclusion criteria
- Adults aged 19 years or older.
- Diagnosed with hypertension.
- Regular use of antihypertensive medication for at least two years.
- Access to a home blood pressure monitor.
- Comprehensive medical records available for the past year.
Exclusion criteria
- \. Participants who are unable to consent or who might not reliably use the home monitoring app.
Where it is running
2 locations listed.
- Korea University Anam Hospital - Seoul, South Korea
- Korea Univeristy Guro Hospital - Seoul, South Korea